Event & Product News

Gerresheimer supplies the primary packaging for dexamethasone

This is the plastic can DB39 from Gerresheimer in which the dexamethasone tablets for the treatment of seriously ill Covid 19 patients are filled.

Düsseldorf, July 20, 2020: Gerresheimer has been commissioned by a well-known customer to produce plastic containers in which the active ingredient dexamethasone is to be filled. According to a study, the active ingredient can reduce the mortality of people who are seriously ill with Covid 19. Only recently, the medical journal and other media reported that the World Health Organization (WHO) had called for an increase in the production of the active ingredient dexamethasone.

"Thanks to globally standardized processes and technologies, we are able to produce flexibly, locally and sustainably. This also includes optimizing procurement and transport routes for our customers," says Jens Friis, Vice President Europe & Latin America at Primary Plastic Packaging, responsible for sales. "For the packaging of dexamethasone, we supply 100ml drug cans with closures. "He explains that already in December 2019 the first mould was successfully transferred to the production site in Vaerloese, Denmark, in order to be able to supply local European markets in an optimal way.

As a specialist for pharmaceutical primary packaging, Gerresheimer for the packaging of the active ingredient. Even at the beginning of the corona pandemic, the company responded flexibly to its customers' requests for containers for filling hand disinfectants. At Gerresheimer the factors of procurement security, supply chain management and clearly defined throughput times are decisive key factors for high customer satisfaction in the service of people's health.

Source

www.aerzteblatt.de

Pharmaceutical bottles and containers made of plastic

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industry. With special products made of glass and plastic the company contributes to health and well-being. Gerresheimer is represented worldwide and with around 10,000 employees produces where its customers and markets are. With plants in Europe, America and Asia Gerresheimer generates sales of around €1.4 billion. The wide range of products includes pharmaceutical packaging as well as products for the simple and safe administration of drugs: Insulin pens, inhalers, micropumps, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medications with closure and safety systems, and packaging for the cosmetics industry.

Contact
Contact us!
Communication & Marketing
Mail
Press
Phone
+49 211 61 81 246
Mail